This Podcast Will Kill You
This Podcast Will Kill You

Ep 157 Retinoids Part 2: …how it’s going

That same little bottle of retinol serum sitting on your bathroom counter - how does it work? Does it actually work? Those are the questions we’re taking on in part two of our retinoids two-parter. The answers, as you might expect, are complicated. Because as it turns out, “retinoid” is a catch-all

Featured Speakers

Exactly Right and iHeartPodcasts Host

Topics Discussed

Episode Summary

Executive Summary: The episode explains what retinoids are, how prescription tretinoin works in skin, and why it has evidence for treating acne, psoriasis, and photoaging. It then contrasts that evidence with the weaker, heavily industry-biased evidence for over-the-counter retinol products, arguing that cosmetic marketing often outpaces regulation and science.

Main Topics: What retinoids are: Defines retinoids as vitamin A derivatives or vitamin A-like compounds that bind retinoid receptors and alter gene expression in skin. Skin structure and mechanism: Explains the epidermis, dermis, and stratum corneum, and how retinoids affect keratinocyte turnover, collagen production, and skin barrier function. Medical uses of prescription retinoids: Reviews established uses for acne, psoriasis, certain keratinization disorders, some skin cancers, and photoaging. Risks and pregnancy concerns: Details irritation, photosensitivity, liver/cholesterol changes, and especially teratogenicity of oral isotretinoin, including strict prescribing controls. Over-the-counter retinoids and evidence quality: Compares OTC retinol, retinaldehyde, and esters with tretinoin, emphasizing lower potency, unstable formulations, weak study quality, and labeling problems. Cosmetic industry and regulation: Critiques the anti-aging skincare market for minimal FDA oversight, heavy marketing claims, and lack of incentive for robust trials.

Key Arguments: Retinoids work by binding retinoid receptors and changing gene expression, which can increase epidermal turnover and collagen production. Prescription tretinoin has the strongest evidence for improving acne and some signs of photoaging. Oral isotretinoin is highly effective for severe acne but carries major teratogenic risk and requires strict pregnancy-prevention controls. Topical retinoids can irritate skin and increase photosensitivity, so benefits come with meaningful tolerability tradeoffs. Over-the-counter retinoids may help some signs of photoaging, but the evidence is weaker, often industry-funded, and difficult to interpret. Cosmetic products are not regulated like drugs, so consumers cannot easily know what concentration or quality they are actually getting. The anti-aging market is huge, but market size does not equal clinical proof of effectiveness.

Data Points: Anti-aging market size (1988): $3 billion - Quoted from an article introducing Retin-A’s rise as an anti-wrinkle product Anti-aging market size (2021): $63 billion - Used to show the scale of the modern anti-aging skincare market Current anti-aging market estimate: $68–72 billion - Range cited from multiple sources in the episode Retinol potency vs tretinoin: About 10x less potent - Approximate comparison of a common OTC retinol to prescription tretinoin Vitamin A receptor types: About 6 retinoid receptors - Mentioned as the receptor family through which retinoids act Time to see effects: Weeks to months - Typical timeframe before visible retinoid benefits appear Pregnancy prevention window for isotretinoin: Start 1 month before and continue 1–3 months after - Described as part of the strict prescribing guidance for oral isotretinoin Prescription supply interval: 30 days - Monthly dispensing limit for isotretinoin in many settings

Pivotal Quotes: "Retinoids, as a large group, are essentially all either vitamin A derivatives. Or they function like vitamin A in our bodies or in our skin." — Erin Welsh: Core definition of retinoids and their biological role "The bottom line is that while we have evidence that some of these might work. We don't have the type of evidence that you would expect from a drug, and we will probably never have that kind of evidence." — Erin Welsh: Summary of the evidence gap for OTC retinoid cosmetics "The anti-aging market is. In 2021, it was estimated to be valued at $63 billion." — Erin Welsh: Illustrates the commercial scale driving the skincare industry

Implications: Listeners should understand that tretinoin has real medical evidence, but most OTC anti-aging retinoids are far less certain. The episode warns consumers to be skeptical of cosmetic claims and to weigh benefit, irritation, cost, and pregnancy risk carefully.

🔓 Sign Up for Unlimited Episode Search

About This Podcast Will Kill You

View all episodes from This Podcast Will Kill You